Scientists can now buy the direct-to-consumer sequencing product, and research participants can join 23andMe’s database.

The personal genomics firm is ramping up its suite of disease-related genetic tests.

The genomic entrepreneur has struck a deal with a South African health insurer to sequence the exomes of its customers.

Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.

With $100 million in initial funding, Helix aims to make personal genomics accessible.

The personal genomics firm announces plans to make medicines.

The US Food and Drug Administration will allow the personal genomics company to resume a disease-risk analysis.

The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.

British consumers can buy the genetic testing-associated health prediction service forbidden by the US government.

Until health care becomes truly personalized, race and ethnicity will continue to be important clues guiding medical treatments.